Celltech Group, Ixsys deal

Celltech Biologics (Slough, U.K.) will manufacture for clinical trials GMP-quality Vitaxin, a humanized antibody under development by Ixsys (San Diego) to inhibit angiogenesis associated with most cancers and certain ophthalmic diseases. ...